Anthropic has acquired the emerging biotech AI company Coefficient Bio in a transaction valued at $400 million, paid in stock, as reported by sources including The Information and journalist Eric Newcomer. This acquisition aligns with Anthropic's ongoing expansion into the healthcare and life sciences sectors, building on its October introduction of Claude for Life Sciences—a specialized tool designed to assist scientific researchers in accelerating discoveries.

Coefficient Bio was founded just eight months ago by Samuel Stanton and Nathan C. Frey, both of whom previously held roles in computational drug discovery at Genentech’s Prescient Design. The startup focused on applying artificial intelligence to streamline and enhance efficiency in drug discovery and various other areas of biological research.

The small team, comprising approximately 10 employees, is anticipated to integrate into Anthropic’s dedicated health and life sciences division.